Board of Directors

Founder in 1976 of the Helsinn Group, Switzerland.
Founder in 1984 and Chairman of HAS Healthcare Advanced Synthesis SA, Switzerland.
Board Member of 3B Future Holding SA, Switzerland.
Co-founder in 2015 with his wife, Anna Braglia, and President of Fondazione Gabriele e Anna Braglia, Switzerland, that is dedicated to cultural and educational art, supports and promotes art exhibitions, conferences and other cultural activities related to modern and contemporary art.

Vice Chairman of the Board of HAS Healthcare Advanced Synthesis SA, Switzerland.
Honorary Chairman of Farma Industria Ticino (Association of the Ticino Pharmaceutical Industry), Switzerland..
Member of the Board of Directors of the University of Applied Sciences and Arts (SUPSI) and of the Advisory Board of BIOS+ Switzerland.
Chairman of the Board of the Life Sciences Competence Center of Swiss Innovation Park Ticino.
Holds a PhD in Chemistry from the Federal Institute of Technology (ETH) in Zurich, Switzerland.

Board Member of HAS Healthcare Advanced Synthesis SA, Switzerland.
Executive Chairman of the Helsinn Group. Member of the Board of Helsinn Healthcare SA, Switzerland.
Vice Chairman and Group CEO at 3B Future Holding SA, Switzerland.
Managing Director at 3B Future Health Ventures Sarl., Monaco and General Partner of 3B Future Health funds, Luxembourg.
Member of the Board at Medacta International SA, Switzerland, an international company specializing in the design,.
Co-founder and a Member of the Board of Gui Sheng Tang Sinomedica Holding SA, Switzerland
Member of the Board of the Conquer Cancer, the ASCO Foundation, USA.
Member of the Board of the Helmut Horten Foundation, Switzerland.
Member of the Board of Trustees of Fondazione ticinese per la ricerca sul cancro, Switzerland.
Co-founder and Chairman of Fondazione Nuovo Fiore in Africa, Switzerland
Board Member of the Fondazione Gabriele e Anna Braglia, Switzerland,

Joined the company in 1994
CEO at HAS Healthcare Advanced Synthesis SA, Switzerland since 2022
Board Member of HAS Healthcare Advanced Synthesis SA, Switzerland
Member of the Committee of Farma Industria Ticino (Association of the Ticino Pharmaceutical Industry), Switzerland.
Member of AITI (Ticino Industrial Association), Switzerland.
Holds a PhD & degree in Chemistry - Swiss Federal Institute of Technology in Zurich.

Resident Partner of Bär & Karrer, Switzerland, since 2001.
Board Member of HAS Healthcare Advanced Synthesis SA, Switzerland.
Board Member of Helsinn SA, Switzerland.
He has a broad experience in advising large multinational corporations on tax and legal matters, particularly in establishing and moving international and regional headquarters in and out of Switzerland.
He is very experienced in coordinating legal and tax advice in M&A projects and assists private clients in legal and tax matters.
University of Bern: lic. iur.
Certified Federal Tax Expert

Joined HAS Healthcare Advanced Synthesis SA, Switzerland in 2023.
Board Member of HAS Healthcare Advanced Synthesis SA, Switzerland.
Assistant Marketing and Communications Manager.
Holds a Bachelor in Global Business Management at Regent's University London.
Holds a Master's Degree in International Marketing at Hult International Business School in London.

Gabriele Pietro Braglia